This inventor holds 4 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignees: Xendo Holding B.v., Biosana Pty Ltd. Active years: 2010-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010-2018
Title: Jacob Arthur Tijsterman: Innovator in Biopharmaceutical Processing
Introduction
Jacob Arthur Tijsterman is a notable inventor based in Haarlem, Netherlands. He has made significant contributions to the field of biopharmaceutical processing, holding a total of 4 patents. His work focuses on innovative methods that enhance the efficiency of biopharmaceutical production.
Latest Patents
Tijsterman's latest patents include groundbreaking inventions such as "Discontinuous fed batch processing with the use of alternating bioreactors." This invention pertains to the discontinuous fed batch cell culturing of mammalian cells, specifically CHO cells, utilizing alternating bioreactors. It also involves the discontinuous separation of biomass from biological substances, particularly monoclonal antibodies and waste components. Another significant patent is the "Method and device for continuous membrane adsorption." This invention provides a method and system for yielding biopharmaceutical products through a chromatographic separation process. It includes a plurality of membrane adsorber cartridges and valves that allow for the operation in a countercurrent flow mode, enabling the recycling of cartridges during the purification of a batch.
Career Highlights
Throughout his career, Tijsterman has worked with several prominent companies, including Xendo Holding B.V. and Biosana Pty Ltd. His experience in these organizations has contributed to his expertise in biopharmaceutical processing and innovation.
Collaborations
Tijsterman has collaborated with notable professionals in his field, including Jozef Anton Mari Pennings and Marc Antonius T Bisschops. These collaborations have further enriched his work and contributed to advancements in biopharmaceutical technologies.
Conclusion
Jacob Arthur Tijsterman is a distinguished inventor whose contributions to biopharmaceutical processing have made a significant impact in the industry. His innovative patents and collaborations reflect his commitment to advancing biopharmaceutical technologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile